A novel strategy for the tumor angiogenesis-targeted gene therapy: Generation of angiostatin from endogenous plasminogen by protease gene transfer

Cancer Gene Therapy

Volumn 7, Issue 4, 2000, Pages 589-596

  Matsuda, Kant M ^a   Madoiwa, Seiji ^a   Hasumi, Yoko ^a   Kanazawa, Takeharu ^a   Saga, Yasushi ^a   Kume, Akihiro ^a   Mano, Hiroyuki ^a   Ozawa, Keiya ^a   Matsuda, Michio ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Angiostatin; Anti angiogenesis; Elastase 1; Gene therapy; Lewis lung carcinoma

Indexed keywords

ANGIOSTATIN; ELASTASE; PLASMINOGEN; PROTEINASE;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; LEWIS CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SECRETION;

ANIMALIA; SUIDAE;

EID: 0034115389     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700147     Document Type: Article

References (31)

1. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285:1182-1186.
2. Folkman J. Tumor angiogenesis. In: Holland JF, Bast RC Jr, Morton DL, Frei E III, Kufe DW, Weichselbaum RP, eds. Cancer Medicine. 4th ed. Baltimore, Md: Williams & Wilkins; 1997;181-204.
3. O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 1994;79:315-328.
4. Cao Y, Ji RW, Davidson D, et al. Kringle domains of human angiostatin: characterization of the anti-proliferative activity on endothelial cells. J Biol Chem. 1996;46: 29461-29467.
5. Lee TH, Rhim T, Kim SS. Prothrombin kringle-2 domain has a growth inhibitory activity against basic fibroblast growth factor-stimulated capillary endothelial cells. J Biol Chem. 1998;273:28805-28812.
6. Date K, Matsumoto K, Kuba K, Shimura H, Tanaka M, Nakamura T. Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor. Oncogene. 1998;17:3045-3054.
7. Panetti TS, Chen H, Misenheimer TM, Getzler SB, Mosher DF. Endothelial cell mitogenesis induced by LPA: inhibition by thrombospondin-1 and thrombospondin-2. J Lab Clin Med. 1997;129:208-216.
8. O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 1997;88:277-285.
9. Tanaka T, Cao Y, Folkman J, Fine HA. Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA. Cancer Res. 1998;58:3362-3369.
10. Cao Y, O'Reilly MS, Marshall B, Flynn E, Ji RW, Folkman J. Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases. J Clin Invest. 1998;101:1055-1063.
11. Griscelli F, Li H, Bennaceur-Griscelli A, et al. Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest. Proc Natl Acad Sci USA. 1998;95:6367-6372.
12. Nguyen JT, Wu P, Clouse ME, Hlatky L, Terwilliger EF. Adeno-associated virus-mediated delivery of antiangiogenic factors as an antitumor strategy. Cancer Res. 1998; 58:5673-5677.
13. Dong Z, Yoneda J, Kumar R, Fidler IJ. Angiostatin-mediated suppression of cancer metastases by primary neoplasms engineered to produce granulocyte/macrophage colony-stimulating factor. J Exp Med. 1998;188:755-763.
14. Tanabe T, Sugo S, Matsuda M. Synthesis of protein C in human umbilical vein endothelial cells. J Biochem. 1991; 109:924-928.
15. Miller AD, Rosman GJ. Improved retroviral vectors for gene transfer and expression. Biotechniques. 1989;7:980-990.
16. Onishi M, Kinoshita S, Morikawa Y, et al. Application of retrovirus-mediated expression cloning. Exp Hematol. 1996;24:324-329.
17. Duke GM, Hoffmann MA, Palmenberg AC. Sequence and structural elements that contribute to efficient encephalomyocarditis virus RNA translation. J Virol. 1992;66:1602-1609.
18. Matsuda KM, Kume A, Ueda Y, Urabe M, Hasegawa M, Ozawa K. Development of a modified selective amplifier gene for hematopoietic stem cell gene therapy. Gene Ther. 1999;6:1038-1044.
19. Xu R, Kume A, Matsuda KM, et al. A selective amplifier gene for tamoxifen-inducible expansion of hematopoietic cells. J Gene Med. 1999;1:236-244.
20. Shirasu Y, Yoshida H, Mikayama T, Matsuki S, Tanaka J, Ikenaga H. Isolation and expression in Escherichia coli of a cDNA clone encoding porcine pancreatic elastase. J Biochem. 1986;99:1707-1712.
21. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227:680-685.
22. Deutsch DG, Mertz ET. Plasminogen purification from human plasma by affinity chromatography. Science. 1970; 170:1095-1096.
23. 2-plasmin inhibitor complex: utilization of two monoclonal antibodies differentially recognizing respective components of the complex. Blood Coagul Fibrinolysis. 1995;6:249-258.
24. Madoiwa S, Arai K, Ueda Y, et al. A battery of monoclonal antibodies that induce unique conformations to evolve cryptic but constitutive functions of plasminogen. J Biochem. 1997;121:278-287.
25. Lijnen HR, Ugwu F, Bini A, Collen D. Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3). Biochemistry. 1998;37:4699-4702.
26. Patterson BC, Sang QA. Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type 4 collagenase (MMP-9). J Biol Chem. 1997;272: 28823-28825.
27. Dong Z, Kumer R, Yang X, Fidler IJ. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell. 1997;88:801-810.
28. Stathakis P, Fitzgerald M, Matthias LJ, Chesterman CN, Hogg PJ. Generation of angiostatin by reduction and proteolysis of plasmin. J Biol Chem. 1997;272:20641-20645.
29. Gately S, Twardowski P, Stack MS, et al. The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin. Proc Natl Acad Sci USA. 1997;94:10868-10872.
30. Kessler PD, Podsakoff GM, Chen X, et al. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc Natl Acad Sci USA. 1996;93:14082-14087.
31. Marais R, Spooner RA, Stribbling SM, Light Y, Martin J, Springer CJ. A cell surface tethered enzyme improves efficiency in gene-directed enzyme prodrug therapy. Nat Biotechnol. 1997;15:1373-1377.